Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Intraoral electrostimulator for xerostomia relief : a long-term, multicenter, open-label, uncontrolled, clinical trial (CROSBI ID 185360)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Alajbeg, Ivan ; Falcão, Denise P. ; Tran, Simon D. ; Martín-Granizo, Rafael ; Lafaurie, Gloria I. ; Matranga, Domenica ; Pejda, Slavica ; Vuletić, Lea ; Mantilla, Rubén ; Leal, Soraya C. et al. Intraoral electrostimulator for xerostomia relief : a long-term, multicenter, open-label, uncontrolled, clinical trial // Oral surgery, oral medicine, oral pathology and oral radiology, 113 (2012), 6; 773-781. doi: 10.1016/j.oooo.2012.01.012

Podaci o odgovornosti

Alajbeg, Ivan ; Falcão, Denise P. ; Tran, Simon D. ; Martín-Granizo, Rafael ; Lafaurie, Gloria I. ; Matranga, Domenica ; Pejda, Slavica ; Vuletić, Lea ; Mantilla, Rubén ; Leal, Soraya C. ; Barreto Bezerra, Ana C. ; Ménard, Henri A. ; Kimoto, Suguru ; Pan, Shaoxia ; Maniegas, Lourdes ; Krushinski, Cheryl A. ; Melilli, Dario ; Campisi, Giuseppina ; Paderni, Carlo ; Bautista Mendoza, Gloria R. ; Yepes, Juan F. ; Lindh, Liselott ; Koray, Meltem ; Mumcu, Gonca ; Elad, Sharon ; Zeevi, Itai ; Aldape Barrios, Beatriz C. ; López Sánchez, Rodrigo M. ; Lassauzay, Claire ; Fromentin, Olivier ; Beiski, Ben Z. ; Strietzel, Frank P. ; Konttinen, Yrjö T. ; Wolff, Andy ; Zunt, Susan L.

engleski

Intraoral electrostimulator for xerostomia relief : a long-term, multicenter, open-label, uncontrolled, clinical trial

A previous sham-controlled multinational study demonstrated the short-term efficacy and safety for xerostomia treatment of an intraoral device that delivers electrostimulation to the lingual nerve. The objective of this study was to test the hypothesis that those beneficial effects would be sustained over an 11-month period. The device was tested on a mixed sample of 94 patients with xerostomia in an open- label, uncontrolled, prospective multicenter trial. Statutory outcome assessments were done at 5th, 8th, and 11th months and analyzed by multiple comparisons. Improvements achieved at month 5 from baseline were sustained throughout the follow-up period for the primary outcome, xerostomia severity, and the secondary outcomes resting whole salivary flow rate, xerostomia frequency, oral discomfort, and difficulties in speech, swallowing, and sleeping. No significant side effects were detected. The beneficial effects of a removable intraoral electrostimulating device were sustained for an 11-month period.

xerostomia; intraoral saliva electrostimulator

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

113 (6)

2012.

773-781

objavljeno

2212-4403

10.1016/j.oooo.2012.01.012

Povezanost rada

Temeljne medicinske znanosti, Kliničke medicinske znanosti, Dentalna medicina

Poveznice
Indeksiranost